Astellas Pharma Inc. - Capital Expenditures

Astellas Pharma Inc.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.

The item "Capital-Expenditures" stands at 40.40 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 06/30/2018.

Astellas Pharma Inc.'s first quarter result of 12.81 Billion JPY for the item "Capital Expenditures" represents an increase of 32.05 percent compared to it's fourth quarter result of the company's last fiscal year.

Also, Astellas Pharma Inc.'s first quarter result of 12.81 Billion JPY for the item "Capital Expenditures" represents a decrease of -8.49 percent compared to it's first quarter result of last year.

Looking again at the trailing twelve months series (TTM), Astellas Pharma Inc.'s first quarter result of 40.40 Billion JPY for the item "Capital Expenditures" represents a decrease of -2.86 percent compared to it's fourth quarter result of the company's last fiscal year.


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -49.58 percent compared to the value the year prior.
The 1 year change in percent is -49.58.
The 3 year change in percent is -45.98.
The 5 year change in percent is -59.86.
The 10 year change in percent is -49.15.

The Serie's long term average value is 69.44 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 41.82 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2018, to it's latest available value, on 06/30/2025, is +0.29%.
The Serie's change in percent from it's maximum value, on 03/31/2016, to it's latest available value, on 06/30/2025, is -65.79%.